Health
Problem LalDawaiyon ka review time 90 se 45 din, kya dhamaka hai!
Arre bhai, suno suno! Union health ministry ne bola hai ki naye dawaon ke liye review time 90 din se 45 din ho gaya hai! Kya baat hai! Ab CDSCO ko sirf inform karna hai, permission nahi leni! High-risk drugs ka kya hoga, samajh nahi aa raha! Lagta hai March tak sab kuch badal jayega, Daya ko bhi khush karne ka mauka milega! Kya dhamaka hai bhai!
few days ago | Sanket Koul
Quick rundown
1.India cuts clinical trial review time by 50%.
2.New drug approval timeline reduced to 45 days.
3.CDSCO introduces online application process.
4.Amendment aims to optimize regulatory resources.
5.Changes expected to boost drug development efficiency.
